SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-19-030904
Filing Date
2019-08-08
Accepted
2019-08-08 17:10:35
Documents
59
Period of Report
2019-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q zfgn-10q_20190630.htm 10-Q 2371754
2 EX-31.1 zfgn-ex311_11.htm EX-31.1 7974
3 EX-31.2 zfgn-ex312_6.htm EX-31.2 7976
4 EX-32.1 zfgn-ex321_10.htm EX-32.1 12978
  Complete submission text file 0001564590-19-030904.txt   6950549

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT zfgn-20190630.xml EX-101.INS 1494004
6 XBRL TAXONOMY EXTENSION SCHEMA zfgn-20190630.xsd EX-101.SCH 43315
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE zfgn-20190630_cal.xml EX-101.CAL 55301
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE zfgn-20190630_def.xml EX-101.DEF 107563
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE zfgn-20190630_lab.xml EX-101.LAB 334350
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE zfgn-20190630_pre.xml EX-101.PRE 239720
Mailing Address 175 PORTLAND STREET 4TH FLOOR BOSTON MA 02114
Business Address 175 PORTLAND STREET 4TH FLOOR BOSTON MA 02114 617-622-4003
ZAFGEN, INC. (Filer) CIK: 0001374690 (see all company filings)

IRS No.: 203857670 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36510 | Film No.: 191010534
SIC: 2834 Pharmaceutical Preparations